For example, rituximab was shown to be effective in treating a case of long-standing, poorly controlled RA in a patient previously exposed to multiple TNF inhibitors and who developed immune-mediated membranoproliferative glomerulonephritis [46]. Here, TNF is linked to rheumatoid arthritis.